JP2024502175A5 - - Google Patents

Info

Publication number
JP2024502175A5
JP2024502175A5 JP2023541658A JP2023541658A JP2024502175A5 JP 2024502175 A5 JP2024502175 A5 JP 2024502175A5 JP 2023541658 A JP2023541658 A JP 2023541658A JP 2023541658 A JP2023541658 A JP 2023541658A JP 2024502175 A5 JP2024502175 A5 JP 2024502175A5
Authority
JP
Japan
Prior art keywords
alkyl
haloalkyl
alkylene
groups
heterocycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023541658A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024502175A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2022/050016 external-priority patent/WO2022147622A1/en
Publication of JP2024502175A publication Critical patent/JP2024502175A/ja
Publication of JP2024502175A5 publication Critical patent/JP2024502175A5/ja
Pending legal-status Critical Current

Links

JP2023541658A 2021-01-07 2022-01-07 Nuakキナーゼの阻害剤としてのイソインドリノンアミノピリミジン化合物、その組成物及び使用 Pending JP2024502175A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163134747P 2021-01-07 2021-01-07
US63/134,747 2021-01-07
PCT/CA2022/050016 WO2022147622A1 (en) 2021-01-07 2022-01-07 Isoindolinone aminopyrimidine compounds as inhibitors of nuak kinases, compositions and uses thereof

Publications (2)

Publication Number Publication Date
JP2024502175A JP2024502175A (ja) 2024-01-17
JP2024502175A5 true JP2024502175A5 (cg-RX-API-DMAC7.html) 2024-12-10

Family

ID=82357069

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023541658A Pending JP2024502175A (ja) 2021-01-07 2022-01-07 Nuakキナーゼの阻害剤としてのイソインドリノンアミノピリミジン化合物、その組成物及び使用

Country Status (7)

Country Link
US (1) US12643886B2 (cg-RX-API-DMAC7.html)
EP (1) EP4277902A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024502175A (cg-RX-API-DMAC7.html)
CN (1) CN116940565A (cg-RX-API-DMAC7.html)
AU (1) AU2022206470A1 (cg-RX-API-DMAC7.html)
CA (1) CA3204401A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022147622A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102939283B1 (ko) * 2022-05-03 2026-03-13 한국화학연구원 5-클로로-2,4-다이아미노피리미딘을 포함하는 키나아제 억제 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
EP4587423A1 (en) * 2022-09-12 2025-07-23 MiHKAL GmbH Novel nootropic prodrugs of phenethylamine
KR20240156074A (ko) * 2023-04-21 2024-10-29 (주)엠디바이오팜 Hpk1 및 mlk3 저해제 및 이를 함유하는 항암용 조성물
CN116947764B9 (zh) * 2023-07-13 2025-07-25 特科罗生物科技(成都)有限公司 一种嘧啶胺类nuak抑制剂及其制备方法和用途
KR20250041906A (ko) * 2023-09-19 2025-03-26 (주)엠디바이오팜 Hpk1 및 mlk3 저해 활성을 갖는 신규한 화합물 및 이를 함유하는 항암용 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE542801T1 (de) * 2003-08-15 2012-02-15 Novartis Ag Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine
US7521457B2 (en) * 2004-08-20 2009-04-21 Boehringer Ingelheim International Gmbh Pyrimidines as PLK inhibitors
GB0419161D0 (en) * 2004-08-27 2004-09-29 Novartis Ag Organic compounds
EP1966207A2 (en) 2005-12-21 2008-09-10 Pfizer Products Inc. Pyrimidine derivatives for the treatment of abnormal cell growth
MX2009004426A (es) * 2006-10-23 2009-08-12 Cephalon Inc Derivados biciclicos fusionados de 2,4-diaminopirimidina como inhibidores alk y c-met.
HRP20170317T1 (hr) 2008-02-15 2017-04-21 Rigel Pharmaceuticals, Inc. Spojevi pirimidin-2-amina i njihova uporaba kao inhibitora jak kinaza
JP2011523646A (ja) * 2008-05-21 2011-08-18 アリアド・ファーマシューティカルズ・インコーポレイテッド キナーゼ阻害剤としてのリン誘導体
WO2010090875A1 (en) * 2009-01-21 2010-08-12 Rigel Pharmaceuticals, Inc. Derivatives of n2-(3-pyridil or phenyl)-n4-(4-piperidyl)-2,4-pyrimidinediamine useful in the treatment of inflammatory, autoimmune or proliferative diseases
CA2788450A1 (en) 2009-12-30 2011-07-07 Arqule, Inc. Substituted naphthalenyl-pyrimidine compounds
KR20130139999A (ko) 2010-10-14 2013-12-23 어리어드 파마슈티칼스, 인코포레이티드 Egfr-유도된 암의 세포 증식을 억제하는 방법
TWI810172B (zh) * 2017-01-26 2023-08-01 南韓商韓美藥品股份有限公司 嘧啶化合物及包括其的藥學組成物
US20230096028A1 (en) 2019-03-01 2023-03-30 Revolution Medicines, Inc. Bicyclic heterocyclyl compounds and uses thereof
HUE065486T2 (hu) 2019-05-10 2024-05-28 Deciphera Pharmaceuticals Llc Fenilaminopirimidinamid autophágia inhibitorok és azok felhasználási eljárásai
US20230227484A1 (en) * 2020-05-29 2023-07-20 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Pyrimidine compound as axl inhibitor

Similar Documents

Publication Publication Date Title
JP2025028934A (ja) ケタミンのプロドラッグ、組成物及びそれらの使用
ES2707534T3 (es) Compuestos útiles como inmunomoduladores
JP6824954B2 (ja) mIDH1阻害剤としての5−ヒドロキシアルキルベンズイミダゾール
JP2022520448A5 (cg-RX-API-DMAC7.html)
JP2025081607A (ja) 統合的ストレス経路のプロドラッグ調節剤
JP2021529812A5 (cg-RX-API-DMAC7.html)
JP6883049B2 (ja) アミノチアゾール化合物及びその使用
ES2675074T3 (es) Compuestos de aril-fenil-sulfonamida-fenileno y su uso
JP2024530952A5 (cg-RX-API-DMAC7.html)
JP2014503567A5 (cg-RX-API-DMAC7.html)
CN112218850A (zh) 整合应激通路的调节剂
JP2024502174A5 (cg-RX-API-DMAC7.html)
TW201808887A (zh) 整合應激途徑之調節劑
KR20190041471A (ko) 케모카인 수용체 조절제 및 이의 용도
JP6824952B2 (ja) mIDH1阻害剤としての2−アリール−および2−アリールアルキル−ベンズイミダゾール
PH12014501626B1 (en) Therapeutically active compounds and their methods of use
US20110178087A1 (en) Compositions and Their Use as Anti-Tumor Agents
IL279800B1 (en) Selective allosteric inhibitors of epidermal growth factor receptor mutants, pharmaceutical preparations containing them and their use
RU2006118785A (ru) Новые нитрофенилипритные и нитрофенилазиридиновые спирты и их соответствующие фосфаты и их применение в качестве нацеленных цитотоксическихих средств
JP2024520630A5 (cg-RX-API-DMAC7.html)
JP2022550353A5 (cg-RX-API-DMAC7.html)
JP2017137323A (ja) 新規抗がん剤
RU2004104329A (ru) Ацилсемикарбазиды как ингибиторы циклинзависимой киназы, полезные в качестве противораковых и противопролиферативных агентов
JP2020530479A5 (cg-RX-API-DMAC7.html)
CN110049768A (zh) 酚噻嗪衍生物及其使用方法